Biosino Bio-Technology and Science Incorporation (HKG:8247)

HKG:8247 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	43.52	68.21	63.41	77.35	44.47
Short-Term Investments	0.86	6.75	8.68	6.96	6.27
Cash & Short-Term Investments	44.38	74.96	72.09	84.31	50.74
Cash Growth	-40.80%	3.98%	-14.49%	66.17%	-7.82%
Accounts Receivable	106.68	121.54	179.8	215.51	207.44
Receivables	137.78	152.7	212.45	246.67	241.87
Inventory	43.61	53.76	60.41	55.49	60
Other Current Assets	4.24	3.98	5.18	11	55.47
Total Current Assets	230	285.41	350.14	397.46	408.08
Property, Plant & Equipment	61.49	74.55	83.68	85.17	106.84
Long-Term Investments	74.44	74.66	78.45	66.1	60.81
Other Intangible Assets	13.79	18.69	20.45	23.36	22.3
Long-Term Accounts Receivable	0.5	0.5	0.5	2.7	0.77
Long-Term Deferred Tax Assets	9.36	5.37	3.23	3.93	3.49
Long-Term Deferred Charges	-	-	6.09	3.08	4.88
Other Long-Term Assets	17.55	18.2	20.71	21.44	0.6
Total Assets	407.12	477.37	563.25	603.24	607.76

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	62.67	87.11	111.54	137.01	145.67
Accrued Expenses	16.71	21.12	28.55	31.2	25.72
Short-Term Debt	97.87	91.86	107.75	102.55	152.57
Current Portion of Long-Term Debt	54.03	51.8	32.99	31	9.18
Current Portion of Leases	0.49	3.36	5.24	3.29	2.51
Current Income Taxes Payable	0	0.01	0.22	3.47	3.47
Current Unearned Revenue	10.01	6.74	12.24	11.63	16.75
Other Current Liabilities	38.63	30.89	22.23	26.11	33.17
Total Current Liabilities	280.41	292.9	320.75	346.26	389.03
Long-Term Debt	8.57	4.56	1.98	7.55	0.03
Long-Term Leases	1.95	2.27	3.49	7.3	9.24
Long-Term Unearned Revenue	-	-	0.07	0.83	2.46
Long-Term Deferred Tax Liabilities	3.24	3.19	5.56	7.2	7.59
Total Liabilities	294.17	302.91	331.85	369.14	408.35

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	144.71	144.71	144.71	144.71	144.71
Retained Earnings	-167.7	-116.55	-74.02	-62.37	-70.48
Comprehensive Income & Other	143.17	139.65	139.7	123.52	101.95
Total Common Equity	120.18	167.81	210.39	205.85	176.17
Minority Interest	-7.23	6.66	21.02	28.26	23.24
Shareholders' Equity	112.96	174.47	231.4	234.11	199.41
Total Liabilities & Equity	407.12	477.37	563.25	603.24	607.76

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	162.91	153.85	151.45	151.69	173.53
Net Cash (Debt)	-118.54	-78.89	-79.36	-67.38	-122.8
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-0.82	-0.55	-0.55	-0.47	-0.85
Filing Date Shares Outstanding	144.71	144.71	144.71	144.71	144.71
Total Common Shares Outstanding	144.71	144.71	144.71	144.71	144.71
Working Capital	-50.4	-7.49	29.39	51.2	19.05
Book Value Per Share	0.83	1.16	1.45	1.42	1.22
Tangible Book Value	106.4	149.12	189.94	182.49	153.88
Tangible Book Value Per Share	0.74	1.03	1.31	1.26	1.06
Buildings	-	-	40.9	40.9	62.93
Machinery	-	-	222.26	225.77	211.41
Leasehold Improvements	-	-	49.68	43.39	39.16

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 28, 2026

Data Sources Report a data error